1. Treatment of Coats' Disease With Combination Therapy of Intravitreal Bevacizumab, Laser Photocoagulation, and Sub-Tenon Corticosteroids.
- Author
-
Sein J, Tzu JH, Murray TG, and Berrocal AM
- Subjects
- Adolescent, Angiogenesis Inhibitors administration & dosage, Child, Child, Preschool, Female, Fluorescein Angiography, Follow-Up Studies, Fundus Oculi, Humans, Infant, Intravitreal Injections, Male, Retinal Telangiectasis diagnosis, Retrospective Studies, Tenon Capsule, Time Factors, Tomography, Optical Coherence, Treatment Outcome, Bevacizumab administration & dosage, Glucocorticoids administration & dosage, Laser Coagulation methods, Retinal Telangiectasis therapy, Visual Acuity
- Abstract
Background and Objective: The authors investigate the efficacy of combination treatment with laser photocoagulation, intravitreal bevacizumab (IVB) (Avastin; Genentech, South San Francisco, CA), and sub-Tenon corticosteroids in Coats' disease., Patients and Methods: Patient records at the Bascom Palmer Eye Institute were reviewed from August 2002 to January 2014. Primary outcome measures were anatomic success, globe salvage, and final visual acuity., Results: Of the 26 patients (26 eyes) reviewed, 20 patients had stage 3A2, four patients had stage 3A1, and two patients had stage 2A. Mean follow-up time was 2.26 years. The median number of applications was five and three for laser and IVB, respectively. Five patients received sub-Tenon triamcinolone injections. Global salvage was achieved in all patients. Final visual acuity outcomes were reasonable: 20/20 to 20/50 in five patients, 20/60 to 20/100 in five patients, and 20/200 or less in 16 patients., Conclusion: Intravitreal injections of bevacizumab used in combination with repetitive laser photocoagulation therapy yielded anatomic success, global salvage, and reasonable visual acuity outcomes. [Ophthalmic Surg Lasers Imaging Retina. 2016;47:443-449.]., (Copyright 2016, SLACK Incorporated.)
- Published
- 2016
- Full Text
- View/download PDF